The role of PCR in the diagnosis and management of CMV in solid organ recipients: What is the predictive value for the development of disease and should PCR be used to guide antiviral therapy?
Michael M. Abecassis*, Alan J. Koffron, Bruce Kaplan, Marguerite Buckingham, Joseph P. Muldoon, Allan J. Cribbins, Dixon B. Kaufman, Jonathan P. Fryer, Joan Stuart, Frank P. Stuart
Dive into the research topics of 'The role of PCR in the diagnosis and management of CMV in solid organ recipients: What is the predictive value for the development of disease and should PCR be used to guide antiviral therapy?'. Together they form a unique fingerprint.